These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5768091)

  • 21. [Effects of metoprolol, practolol, and propranolol after isoprenaline injections in asthmatic patients (author's transl)].
    Svedmyr N; Thiringer G
    Sem Hop; 1980 Apr 18-25; 56(15-16):798-804. PubMed ID: 6246620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potency and time-effect relationship in man of propranolol and H 56-28--comparative studies after oral administration.
    Ablad B; Johnsson G; Norrby A; Sölvell L
    Acta Pharmacol Toxicol (Copenh); 1967; 25():85-94. PubMed ID: 6072575
    [No Abstract]   [Full Text] [Related]  

  • 23. Sweat production during catecholamine infusion in man.
    Allen JA; Roddie IC
    J Physiol; 1972 Apr; 222(1):70P-71P. PubMed ID: 5037106
    [No Abstract]   [Full Text] [Related]  

  • 24. [New special drugs registered in Austria. Praetolol].
    Wien Klin Wochenschr; 1972 Jan; 84(4):69-71. PubMed ID: 5012931
    [No Abstract]   [Full Text] [Related]  

  • 25. Release by amphetamine in man of growth hormone and corticosteroids: the effects of thymoxamine and propranolol.
    Besser GM; Butler PW; Ratcliffe JG; Rees L; Young P
    Br J Pharmacol; 1970 May; 39(1):196P-197P. PubMed ID: 4315989
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of adrenergic agonists and antagonists on the blood pressure and heart rate of the pig fetus.
    Macdonald AA; Colenbrander B; Wensing CJ
    Res Vet Sci; 1984 Jan; 36(1):61-5. PubMed ID: 6143354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological properties of 1-(4'-nitropheynl)-2-isopropylamino-ethanol (INPEA) a new beta-adrenergic receptor antagonist. 3. Direct effects on heart rate, oxygen consumption and rectal temperature and effects on the cardiac and metabolic responses to isoproterenol, adrenaline and noradrenaline in the urethan anesthetized rat.
    Murmann W; Rumore G; Gamba A
    Boll Chim Farm; 1966 Jul; 105(7):512-35. PubMed ID: 6003408
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical-pharmacological studies with a new beta receptor blocking substance (LB 46, Visken)].
    Judmaier G; Dienstl F; Schwingshackl H; Amor H
    Wien Klin Wochenschr; 1970 Dec; 82(50):891-3. PubMed ID: 5491146
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of beta-receptor-blocking agents on physical working capacity and muscular blood circulation in hyperkinetic dysfunction of the blood circulation].
    Kaltenbach M; Becker HJ; Brunn V
    Verh Dtsch Ges Inn Med; 1968; 74():565-9. PubMed ID: 5714382
    [No Abstract]   [Full Text] [Related]  

  • 30. Absence of central nervous system effects of practalol [ICI 50,172; 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide], a new adrenergic beta-receptor blocking drug.
    Estler CJ; Ammon HP
    J Pharm Pharmacol; 1969 Aug; 21(8):554-5. PubMed ID: 4389726
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of a new adrenergic beta-blocking agent (ICI 50,172) on heart rate in relation to its blood levels.
    Fitzgerald JD; Scales B
    Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):467-74. PubMed ID: 5718774
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.
    Ablad B; Brogård M; Ek L
    Acta Pharmacol Toxicol (Copenh); 1967; 25():9-40. PubMed ID: 6072577
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential chronergy of propranolol effects on heart rate in healthy and hypertensive subjects.
    Ruiz-Vega H; Acosta-Urzua LF; Carranza-Madrigal J; Huape-Arreola MS
    Proc West Pharmacol Soc; 1998; 41():71-2. PubMed ID: 9836247
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of cardiac chronotropic action of isoproterenol by Sotalol (MJ 1999) in rat, dog and man.
    Lish PM; Shelanski MV; LaBudde JA; Williams WR
    Curr Ther Res Clin Exp; 1967 Jun; 9(6):311-24. PubMed ID: 4963067
    [No Abstract]   [Full Text] [Related]  

  • 35. [Isoproterenol and cardiovascular reactivity in angina pectoris].
    Starcich R; Barbaresi F; Bacuzzi E; Pavarani A
    G Clin Med; 1966 Aug; 47(8):701-19. PubMed ID: 5989215
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of novocaine on the course of experimental isadrine induced necrosis of the myocardium].
    Kupnovitskaia IG
    Farmakol Toksikol; 1970; 33(3):295-7. PubMed ID: 5453023
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use.
    Schiffelers SL; Blaak EE; Saris WH; van Baak MA
    Clin Pharmacol Ther; 2000 May; 67(5):558-66. PubMed ID: 10824635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular actions of iproveratril.
    Ross G; Jorgensen CR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):504-9. PubMed ID: 6073232
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of adrenergic and cholinergic agents on the membrane permeability of isolated atrial tissue, as measured with 86Rb].
    van Zwieten PA
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):259-60. PubMed ID: 5804282
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.
    Giudicelli JF; Schmitt H; Boissier JR
    J Pharmacol Exp Ther; 1969 Jul; 168(1):116-26. PubMed ID: 5792677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.